A cross-sectional study of seroprevalence in Armenia, 2025: measles, mumps, rubella, and diphtheria
IntroductionPrevention and control of vaccine-preventable infections is a key component of maintaining public health, and the overall state of immunity is the determining factor.Objective of the studyTo study herd immunity of the Armenian population to ...
A. Y. Popova +25 more
doaj +1 more source
Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic. [PDF]
da Silva TMR +5 more
europepmc +1 more source
Measles Virus Neutralizing Antibody Response and Durability Two Years after One or Two Doses of Measles-Mumps-Rubella Vaccine among Young Seronegative Healthcare Workers. [PDF]
Jang B +5 more
europepmc +1 more source
Influence of measles-mumps-rubella vaccine series initiation and completion on influenza vaccination among adolescents. [PDF]
Beeninga FT +4 more
europepmc +1 more source
Reply to Özdemir, "Measles-Mumps-Rubella Vaccine and COVID-19 Relationship". [PDF]
Fidel PL, Noverr MC.
europepmc +1 more source
MMR vaccine (measles, mumps, rubella) : what you need to know
MMR vaccine can prevent measles, mumps, and rubella.mmr.pdf1. Why get vaccinated? -- 2. MMR vaccine -- 3. Talk with your health care provider -- 4. Risks of a vaccine reaction-- 5. What if there is a serious problem? \u2013 6. The National Vaccine Injury
core
Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial. [PDF]
Liu X +9 more
europepmc +1 more source
Comparison of Intralesional Measles, Mumps, Rubella Vaccine and Needling in the Treatment of Recurrent Warts. [PDF]
Kolte SR, Sardesai VR.
europepmc +1 more source

